Actively Recruiting
The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocardial Infarction - A Single-Centre Randomized Control Trial
Led by Universitas Diponegoro · Updated on 2025-07-10
100
Participants Needed
1
Research Sites
38 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn the effect of low level tragus stimulation (LLTS) on echocardiographic parameter in patient with ST-segment Elevation Myocardial Infarction (STEMI) who undergo primart percutaneous coronary intervention (PPCI). It will also learn about the safety of LLTS in such setting. The main questions, it aims to answer are compared with sham control: Does LLTS could alter left ventricular ejection fraction in patients with STEMI? Does LLTS could alter wall motion score index in patients with STEMI? Does LLTS could alter diastolic dysfunction in patients with STEMI? Researchers will compare LLTS to sham LLTS control to see if LLTS have benefit in participants with STEMI participants will divided into two group i.e. treatment group vs control (sham/placebo) group.. Both groups undergo transthoracal echocardiographi examination before and after PPCI..
CONDITIONS
Official Title
The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocardial Infarction - A Single-Centre Randomized Control Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Onset of ST-segment Elevation Myocardial Infarction (STEMI) less than 12 hours
- Participant agrees to join the study
- Killip class I or II at presentation
- Systolic blood pressure above 90 mmHg and/or mean arterial pressure above 65 mmHg
- Sinus rhythm present
You will not qualify if you...
- History of myocardial infarction, stroke, heart failure with reduced ejection fraction, chronic total occlusion on previous coronary angiography, chronic kidney disease with eGFR less than 30 or on hemodialysis, malignancy, hematology disease, autoimmune or other chronic diseases
- Permanent pacemaker
- Acute infection
- Pregnant woman
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dr. Kariadi Central General Hospital
Semarang, Central of Java, Indonesia
Actively Recruiting
Research Team
L
Leo Deddy Pradipta
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here